UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.230

Sortiert nach

Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program

Clinical epidemiology, 2011, Vol.3 (Issue 1), p.139-148

2011

Volltextzugriff (PDF)

Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1997-12, Vol.89 (23), p.1782-1788

1997

Volltextzugriff (PDF)

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting a comparison of their pharmacology and clinical efficacy

Drugs (New York, N.Y.), 1998-02, Vol.55 (2), p.173-189

1998

Volltextzugriff (PDF)

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Annals of oncology, 2019-10, Vol.30 (10), p.1647-1652

2019

Volltextzugriff (PDF)

Phase I and pharmacologic study of topotecan in patients with impaired renal function

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3062-3073

1996

Volltextzugriff (PDF)

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3074-3084

1996

Volltextzugriff (PDF)

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis

Journal of clinical oncology, 1993-03, Vol.11 (3), p.561-569

1993

Volltextzugriff (PDF)

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study

Journal of clinical oncology, 1995-06, Vol.13 (6), p.1430-1435

1995

Volltextzugriff (PDF)

Sequences of taxol and cisplatin: a phase I and pharmacologic study

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1692-1703

1991

Volltextzugriff (PDF)

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

Journal of clinical oncology, 1992-04, Vol.10 (4), p.647-656

1992

Volltextzugriff (PDF)

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330

Sarcoma, 2012, Vol.2012, p.659485-7

2012

Volltextzugriff (PDF)

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

Annals of internal medicine, 1989-08, Vol.111 (4), p.273

1989

Volltextzugriff (PDF)

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

Journal of clinical oncology, 1993-10, Vol.11 (10), p.2010-2020

1993

Volltextzugriff (PDF)

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

Journal of clinical oncology, 1986-05, Vol.4 (5), p.702-709

1986

Volltextzugriff (PDF)

Overview of paclitaxel (TAXOL®) in advanced lung cancer

Seminars in oncology, 1993-08, Vol.20 (4), p.46-49

ETTINGER, D. S

1993

Volltextzugriff (PDF)

Gemcitabine-containing regimens in non-small cell lung cancer: are these standard therapies or not?

Seminars in oncology, 2000-02, Vol.27 (1 Suppl 2), p.1-2

Ettinger, D S

2000

Volltextzugriff (PDF)

Phase I–II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

JNCI : Journal of the National Cancer Institute, 1992-01, Vol.84 (2), p.98-103

1992

Volltextzugriff (PDF)

Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer

Seminars in radiation oncology, 1999-04, Vol.9 (2 Suppl 1), p.148-150

Ettinger, D S

1999

Volltextzugriff (PDF)

Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis

Seminars in oncology, 1995-08, Vol.22 (4 Suppl 10), p.6-18

Ettinger, D S

1995

Volltextzugriff (PDF)

Single-agent paclitaxel in the treatment of small cell lung cancer

Seminars in oncology, 1996-12, Vol.23 (6), p.16-17

ETTINGER, D. S

1996

Volltextzugriff (PDF)

Phase I and pharmacodynamic study of taxol in refractory acute leukemias

Cancer research (Chicago, Ill.), 1989-08, Vol.49 (16), p.4640-4647

1989

Volltextzugriff (PDF)

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

Journal of clinical oncology, 1986-01, Vol.4 (1), p.14-22

1986

Volltextzugriff (PDF)

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma an eastern cooperative oncology group study

Cancer, 1998-09, Vol.83 (6), p.1102-1108

1998

Volltextzugriff (PDF)

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1615-1622

1995

Volltextzugriff (PDF)

The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update

Seminars in oncology, 1995-02, Vol.22 (1 Suppl 2), p.23

Ettinger, D S

1995

Volltextzugriff (PDF)

1 – 25 von 1.230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.014)
Mit Volltextzugriff
(974)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program

Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting a comparison of their pharmacology and clinical efficacy

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Phase I and pharmacologic study of topotecan in patients with impaired renal function

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study

Sequences of taxol and cisplatin: a phase I and pharmacologic study

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

Overview of paclitaxel (TAXOL®) in advanced lung cancer

Gemcitabine-containing regimens in non-small cell lung cancer: are these standard therapies or not?

Phase I–II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer

Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis

Single-agent paclitaxel in the treatment of small cell lung cancer

Phase I and pharmacodynamic study of taxol in refractory acute leukemias

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma an eastern cooperative oncology group study

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study

The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update

Suchergebnisse filtern